English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
An NQO1 dependent ROS and RIP1/RIP3 mediated necroptosis induced in glioma cancer cells by MAM Conference paper
Yu, J., Wu, X.X., Wang, C.X., Sun, W., Hou, Y., Zhang, Y.Y., Li, Z.W., Lu, J., Chen, X. P.. An NQO1 dependent ROS and RIP1/RIP3 mediated necroptosis induced in glioma cancer cells by MAM[C], 2018.
Authors:  Yu, J.;  Wu, X.X.;  Wang, C.X.;  Sun, W.;  Hou, Y.; et al.
Favorite |  | Submit date：2022/08/26
MAM  necroptosis  glioma  
An NQO1 dependent ROS and RIP1/RIP3 mediated necroptosis induced in glioma cancer cells by a natural product, 2-Methoxy-6-acetyl-7-methyljuglone (MAM) Conference paper
Yu, J., Li, Z.W., Hou, Y., Yuan, R.Y.K., Lu, J., Chen, X. P.. An NQO1 dependent ROS and RIP1/RIP3 mediated necroptosis induced in glioma cancer cells by a natural product, 2-Methoxy-6-acetyl-7-methyljuglone (MAM)[C], 2017.
Authors:  Yu, J.;  Li, Z.W.;  Hou, Y.;  Yuan, R.Y.K.;  Lu, J.; et al.
Favorite |  | Submit date：2022/08/26
MAM  necroptosis  NQO1  ROS  RIP1/RIP3  
Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice Journal article
Sun F., Zhang Z.W., Tan E.M., Lim Z.L.R., Li Y., Wang X.C., Chua S.E., Li J., Cheung E., Yong E.-L.. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice[J]. Carcinogenesis, 2016, 37(7), 701-711.
Authors:  Sun F.;  Zhang Z.W.;  Tan E.M.;  Lim Z.L.R.;  Li Y.; et al.
Favorite | TC[WOS]:31 TC[Scopus]:29 | Submit date：2018/12/17
A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants Journal article
Sun F., Indran I.R., Zhang Z.W., Tan M.H.E., Li Y., Lim Z.L.R., Hua R., Yang C., Soon F.-F., Li J., Xu H.E., Cheung E., Yong E.-L.. A novel prostate cancer therapeutic strategy using icaritin-activated arylhydrocarbon-receptor to co-target androgen receptor and its splice variants[J]. Carcinogenesis, 2015, 36(7), 757-768.
Authors:  Sun F.;  Indran I.R.;  Zhang Z.W.;  Tan M.H.E.;  Li Y.; et al.
Favorite | TC[WOS]:53 TC[Scopus]:60 | Submit date：2018/12/17